Related Experiment Video
Updated: Dec 9, 2025
04:37
Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
Published on: June 16, 2023
1.6K
Outcomes in Hypoplastic Left Heart Syndrome
Meghan Kiley Metcalf1, Jack Rychik1
1Division of Cardiology, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Pediatric Clinics of North America
|September 5, 2020
Summary
Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect requiring lifelong management. Advances in prenatal diagnosis, surgical techniques, and specialized care have significantly improved survival rates for affected children.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease Research
- Neonatal Care
Background:
- Hypoplastic left heart syndrome (HLHS) is a critical congenital heart defect characterized by underdevelopment of the left heart.
- Without intervention, HLHS is universally fatal due to the left ventricle's inability to support systemic circulation.
- Significant progress has been made in managing HLHS over the last three decades.
Purpose of the Study:
- To review the current understanding and management strategies for hypoplastic left heart syndrome (HLHS).
- To highlight the advancements contributing to improved survival outcomes in HLHS patients.
- To identify key areas of ongoing research, including single-ventricle physiology and Fontan circulation.
Main Methods:
- Review of recent literature on hypoplastic left heart syndrome (HLHS) management.
- Analysis of survival trends and contributing factors over the past 30 years.
- Discussion of current therapeutic approaches and future research directions.
Main Results:
- Survival rates for HLHS have markedly improved due to a multi-faceted approach.
- Key factors include early prenatal diagnosis, enhanced neonatal intensive care, advanced surgical techniques, and specialized postoperative management.
- Interstage monitoring strategies have also played a crucial role in improving outcomes.
Conclusions:
- Modern management strategies have transformed HLHS from a uniformly fatal condition to one with increasing survival.
- Continued research into single-ventricle physiology and Fontan circulation is essential for optimizing long-term outcomes.
- A multidisciplinary approach is critical for the successful care of individuals with HLHS.
Keywords:
Congenital heart surgeryFetal echocardiographyHypoplastic left heart syndromeNeurocognitive deficits in congenital heart diseaseOutcomes for congenital heart diseaseMore Related Videos
Related Concept Videos
01:22Mitral Stenosis I: Introduction
211
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
211
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
236
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
236
01:17Pathophysiology of Heart Failure
2.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
01:29Cardiomyopathy V: Interprofessional Care
181
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
181
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
165
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
165
01:30Cardiomyopathy II: Dilated Cardiomyopathy
280
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
280